Haleon plc (LON:HLN - Get Free Report) traded down 0.2% during mid-day trading on Monday . The stock traded as low as GBX 373.90 ($4.66) and last traded at GBX 376.90 ($4.70). 24,362,850 shares changed hands during mid-day trading, an increase of 88% from the average session volume of 12,988,258 shares. The stock had previously closed at GBX 377.63 ($4.71).
Haleon Stock Down 0.1 %
The firm has a 50-day simple moving average of GBX 374.07 and a 200 day simple moving average of GBX 368.46. The company has a market capitalization of £34.04 billion, a PE ratio of 3,138.33, a price-to-earnings-growth ratio of 1.49 and a beta of 0.19. The company has a debt-to-equity ratio of 54.18, a current ratio of 0.84 and a quick ratio of 0.93.
Insider Activity at Haleon
In related news, insider Dawn Allen sold 74,679 shares of the business's stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of GBX 372 ($4.64), for a total transaction of £277,805.88 ($346,564.22). Also, insider Alan Stewart bought 33,923 shares of the company's stock in a transaction on Wednesday, November 6th. The stock was bought at an average cost of GBX 368 ($4.59) per share, for a total transaction of £124,836.64 ($155,734.33). 10.74% of the stock is currently owned by corporate insiders.
Haleon Company Profile
(
Get Free Report)
Haleon LSE / NYSE: HLN is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges.
Haleon's portfolio spans five global categories including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health and Digestive Health and other.
Further Reading
Before you consider Haleon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.
While Haleon currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.